Rockwell Medical, Inc.
RMTI
$1.47
$0.2318.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -37.79% | -16.59% | 11.64% | 19.12% | 42.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -37.79% | -16.59% | 11.64% | 19.12% | 42.88% |
| Cost of Revenue | -36.25% | -19.07% | 9.42% | 2.36% | 24.84% |
| Gross Profit | -44.99% | -0.72% | 26.52% | 183.33% | 340.46% |
| SG&A Expenses | -4.54% | 0.73% | 27.70% | 24.91% | 5.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.19% | -15.53% | 11.24% | 3.42% | 20.33% |
| Operating Income | -361.94% | -2.72% | 5.12% | 211.46% | 117.40% |
| Income Before Tax | -534.99% | 12.48% | 50.00% | 188.89% | 110.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -534.99% | 12.48% | 50.00% | 188.89% | 110.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -534.99% | 12.48% | 50.00% | 188.89% | 110.38% |
| EBIT | -361.94% | -2.72% | 5.12% | 211.46% | 117.40% |
| EBITDA | -173.87% | -5.39% | 700.00% | 311.34% | 138.15% |
| EPS Basic | -609.57% | 24.75% | 46.55% | 166.76% | 104.78% |
| Normalized Basic EPS | -571.67% | 21.95% | 57.95% | 169.47% | 104.88% |
| EPS Diluted | -631.91% | 24.75% | 44.01% | 157.14% | 104.78% |
| Normalized Diluted EPS | -596.49% | 21.95% | 57.95% | 167.58% | 104.63% |
| Average Basic Shares Outstanding | 12.67% | 16.30% | 14.75% | 14.65% | 81.31% |
| Average Diluted Shares Outstanding | 7.11% | 16.30% | 14.75% | 17.80% | 90.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |